Abstract
Abstract
Background
Vestibular schwannomas are benign tumours for which various treatments are available. We performed a systematic review of prospective controlled trials comparing the patient-relevant benefits and harms of single-fraction stereotactic radiosurgery (sfSRS) with microsurgical resection (MR) in patients with vestibular schwannoma.
Methods
We searched for randomized controlled trials (RCTs) and non-randomized prospective controlled trials in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and study registries (last search: 09/2021) and also screened reference lists of relevant systematic reviews. Manufacturers were asked to provide unpublished data. Eligible studies investigated at least one patient-relevant outcome. We assessed the risk of bias (high or low) at the study and outcome level. If feasible, meta-analyses were performed. We graded the results into different categories (hint, indication, or proof of greater benefit or harm).
Results
We identified three non-randomized prospective controlled trials of generally low quality with evaluable data on 339 patients with unilateral vestibular schwannoma. There was an indication of greater benefit of sfSRS compared with MR for facial palsy (OR 0.06, 95% CI 0.02–0.21, p < 0.001, 2 studies), hearing function (no pooled estimate available, 2 studies), and length of hospital stay (no pooled estimate available, 2 studies). We found no clinically relevant differences for mortality, vertigo, headaches, tinnitus, balance function, work disability, adverse events, and health-related quality of life.
Conclusions
Our systematic review indicates that sfSRS has greater benefits than MR in patients with unilateral vestibular schwannoma. However, it is unclear whether this conclusion still holds after 2 years, as long-term studies are lacking. It is also unclear whether the effects of sfSRS are similar in patients with bilateral vestibular schwannomas. Long-term prospective studies including patients with this condition would therefore be useful.
Systematic review registration
The full (German language) protocol and report (Commission No. N20-03) are available on the institute’s website: www.iqwig.de/en/projects/n20-03.html
Funder
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Bassem H. Vestibular schwannoma 2019 [Available from: https://www.dynamed.com/condition/vestibular-schwannoma.
2. Park KJ, Vernick DM, Ramakrishna N. Vestibular schwannoma (acoustic neuroma) 2020 [updated 04.03.2020. Available from: https://www.uptodate.com/contents/vestibular-schwannoma-acoustic-neuroma.
3. Evans DG. Neurofibromatosis type 2 2020 [updated 14.02.2020. Available from: https://www.uptodate.com/contents/neurofibromatosis-type-2.
4. Carlson ML, Vivas EX, DJ MC, Sweeney AD, Neff BA, Shepard NT, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on hearing preservation outcomes in patients with sporadic vestibular schwannomas. Neurosurgery. 2018;82(2):E35–E9.
5. Germano IM, Sheehan J, Parish J, Atkins T, Asher A, Hadjipanayis CG, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on the role of radiosurgery and radiation therapy in the management of patients with vestibular schwannomas. Neurosurgery. 2018;82(2):E49–51.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献